Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)

Initial Combination Therapy in a Newly Diagnosed T2DM Patient

The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM.  Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens.   By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.

Medicine

The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM. Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens. By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.

Share Initial Combination Therapy in a Newly Diagnosed T2DM Patient

Sign up to save your podcasts

Initial Combination Therapy in a Newly Diagnosed T2DM Patient

Initial Combination Therapy in a Newly Diagnosed T2DM Patient